Mitomycin or cisplatin chemoradiation with or without maintenance chemotherapy for treatment of squamous-cell carcinoma of the anus (ACT II): a randomised, phase 3, open-label, 2x2 factorial trial

Roger D. James, Robert Glynne-Jones*, Helen M. Meadows, David Cunningham, Arthur Sun Myint, Mark P. Saunders, Timothy Maughan, Alec McDonald, Sharadah Essapen, Martin Leslie, Stephen Falk, Charles Wilson, Simon Gollins, Rubina Begum, Jonathan Ledermann, Latha Kadalayil, David Sebag-Montefiore

*Corresponding author for this work

    Research output: Contribution to journalArticlepeer-review

    574 Citations (Scopus)

    Fingerprint

    Dive into the research topics of 'Mitomycin or cisplatin chemoradiation with or without maintenance chemotherapy for treatment of squamous-cell carcinoma of the anus (ACT II): a randomised, phase 3, open-label, 2x2 factorial trial'. Together they form a unique fingerprint.

    Medicine and Dentistry

    Pharmacology, Toxicology and Pharmaceutical Science